Moneycontrol PRO
HomeNewsBusinessIPOMedicap Healthcare files draft papers with SEBI for Rs 240-crore IPO

Medicap Healthcare files draft papers with SEBI for Rs 240-crore IPO

Medicap Healthcare IPO | The proposed IPO is entirely a fresh issue of equity shares with no offer for sale (OFS) component.

September 23, 2025 / 19:26 IST
Medicap Healthcare IPO News

Medicap Healthcare has filed draft papers with markets regulator SEBI to raise Rs 240 crore through an initial public offering (IPO).

The proposed IPO is entirely a fresh issue of equity shares with no offer for sale (OFS) component, according to the draft red herring prospectus (DRHP) filed on Monday.

The company plans to mobilise Rs 48 crore in a pre-IPO placement round. If this is undertaken, the fresh issue size would be reduced accordingly.

Funds raised through the IPO will be used to purchase plant and machinery for the manufacturing unit, payment of debt of the company and its subsidiary KASR Healthcare, and general corporate purposes.

Click Here To Read All IPO News

Vadodara-based Medicap Healthcare is a manufacturer of critical packaging products for pharmaceutical companies like Euro Head caps and bottle preforms. The company supplies both domestic and international pharma customers.

Its planned listing on stock exchanges is an attempt to increase its capacity as well as widen its balance sheet.

Aryaman Financial Services is the sole book-running lead manager to the public issue.

PTI
first published: Sep 23, 2025 07:26 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347